Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP950286.RAqOyuzISlm8DOTXFNLiDfggrYV51v1k61CvBSCbgrgaY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP950286.RAqOyuzISlm8DOTXFNLiDfggrYV51v1k61CvBSCbgrgaY130_assertion type Assertion NP950286.RAqOyuzISlm8DOTXFNLiDfggrYV51v1k61CvBSCbgrgaY130_head.
- NP950286.RAqOyuzISlm8DOTXFNLiDfggrYV51v1k61CvBSCbgrgaY130_assertion description "[The aim of this study was to evaluate whether the neoadjuvant use of the dexamethasone (DEX) plus octreotide (OCT) regimen can improve the direct anticancer effects of docetaxel (DOC) in the TRAMP-C1 prostate cancer model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP950286.RAqOyuzISlm8DOTXFNLiDfggrYV51v1k61CvBSCbgrgaY130_provenance.
- NP950286.RAqOyuzISlm8DOTXFNLiDfggrYV51v1k61CvBSCbgrgaY130_assertion evidence source_evidence_literature NP950286.RAqOyuzISlm8DOTXFNLiDfggrYV51v1k61CvBSCbgrgaY130_provenance.
- NP950286.RAqOyuzISlm8DOTXFNLiDfggrYV51v1k61CvBSCbgrgaY130_assertion SIO_000772 22210719 NP950286.RAqOyuzISlm8DOTXFNLiDfggrYV51v1k61CvBSCbgrgaY130_provenance.
- NP950286.RAqOyuzISlm8DOTXFNLiDfggrYV51v1k61CvBSCbgrgaY130_assertion wasDerivedFrom befree-2016 NP950286.RAqOyuzISlm8DOTXFNLiDfggrYV51v1k61CvBSCbgrgaY130_provenance.
- NP950286.RAqOyuzISlm8DOTXFNLiDfggrYV51v1k61CvBSCbgrgaY130_assertion wasGeneratedBy ECO_0000203 NP950286.RAqOyuzISlm8DOTXFNLiDfggrYV51v1k61CvBSCbgrgaY130_provenance.